Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Denosumab”

285 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 285 results

Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Large-scale testing (Phase 3)Study completedNCT03027557
What this trial is testing

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.

Who this might be right for
Primary HyperparathyroidismParathyroid AdenomaParathyroid Hyperplasia
Peter Vestergaard 46
Early research (Phase 1)Study completedNCT02053753
What this trial is testing

Bioequivalence Study of Denosumab CP4 Drug Product and Commercially Available Denosumab CP2 Drug Product

Who this might be right for
Healthy Volunteer
Amgen 146
Early research (Phase 1)UnknownNCT05777109
What this trial is testing

Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

Who this might be right for
Healthy
Jiangsu Hansoh Pharmaceutical Co., Ltd. 180
Large-scale testing (Phase 3)Study completedNCT00919711
What this trial is testing

Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy

Who this might be right for
Osteoporosis
Amgen 870
Post-approval studies (Phase 4)Not Yet RecruitingNCT07772609
What this trial is testing

Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD

Who this might be right for
Osteoporosis in Post-menopausal Women
Sahlgrenska University Hospital 216
Testing effectiveness (Phase 2)Study completedNCT00095498
What this trial is testing

Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Amgen 227
Large-scale testing (Phase 3)Active Not RecruitingNCT02051218
What this trial is testing

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerBone Metastases
Swiss Cancer Institute 1,380
Testing effectiveness (Phase 2)Active Not RecruitingNCT03571191
What this trial is testing

Denosumab Treatment for Fibrous Dysplasia

Who this might be right for
Bone DiseasesPain
National Institute of Dental and Craniofacial Research (NIDCR) 9
Testing effectiveness (Phase 2)Study completedNCT04403698
What this trial is testing

The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover

Who this might be right for
Erosive Osteoarthritis
University Hospital, Ghent 30
Large-scale testing (Phase 3)Study completedNCT00091793
What this trial is testing

Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Amgen 332
Not applicableStudy completedNCT02435147
What this trial is testing

Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index

Who this might be right for
OsteoporosisBone Fracture
HealthEast Care System 86
Testing effectiveness (Phase 2)Study completedNCT00043186
What this trial is testing

Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Low Bone Mineral Density
Amgen 412
Post-approval studies (Phase 4)UnknownNCT01983475
What this trial is testing

Denosumab Administration After Spinal Cord Injury

Who this might be right for
OsteoporosisSpinal Cord Injury
James J. Peters Veterans Affairs Medical Center 24
Post-approval studies (Phase 4)Study completedNCT03005678
What this trial is testing

Denosumab Versus Bisphosphonates (Alendronate) in GIOP

Who this might be right for
Osteoporosis
Tuen Mun Hospital 140
Large-scale testing (Phase 3)Study completedNCT05352516
What this trial is testing

Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

Who this might be right for
Postmenopausal
Shanghai Henlius Biotech 514
Not applicableUnknownNCT02932501
What this trial is testing

Medication-related Osteonecrosis of the Jaw (MRONJ) Registry

Who this might be right for
Medication-related Osteonecrosis of the JawBisphosphonate-Associated Osteonecrosis of the Jaw
AO Clinical Investigation and Publishing Documentation 518
Testing effectiveness (Phase 2)UnknownNCT03702140
What this trial is testing

Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy

Who this might be right for
Osteoporosis
Shinshu University 90
Testing effectiveness (Phase 2)Study completedNCT02613416
What this trial is testing

Denosumab and MRI Breast Imaging

Who this might be right for
Breast Cancer
Alison Stopeck 42
Large-scale testing (Phase 3)Study completedNCT02157948
What this trial is testing

Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Amgen 394
Next Page